References
- Hong, C. Y. IL. FARMACO 2001, 56, 41 https://doi.org/10.1016/S0014-827X(01)01017-5
- LG Life Science DMF Number 14524; FDA: Rockville, MD, USA, 1999
- Validation of Analytical Procedures: Text and Methodology Q2(R1), ICH, Federal Register; FDA: Rockville, MD, 2005
- Shirota, O.; Ohtsu, Y.; Nakata, O. J. Chromatogr. Sci. 1990, 28, 553 https://doi.org/10.1093/chromsci/28.11.553
- Kele, M.; Cuiochon, G. J. Chromatogr. 2000, 869, 181 https://doi.org/10.1016/S0021-9673(99)01092-4
- Guideline for Industry, Q1A Stability Testing of New Drug Substances and Products, ICH, Federal Register; FDA: Rockville, MD, 1996
- Reviewer Guidance, Validation of Chromatographic Methods; Center for Drug Evaluation and Research, FDA: Rockville, MD, 1994
- Pathare, D. B.; Jadhav, A. S. J. Pharm. Biomed. Anal. 2006, 41, 1152 https://doi.org/10.1016/j.jpba.2006.02.024
Cited by
- Validated stability-indicating HPLC method for analysis of gemifloxacin in tablet formulations vol.23, pp.1, 2011, https://doi.org/10.1556/AChrom.23.2011.1.6